PSA Screening Reduces Prostate Cancer Mortality, European Study Shows

Share this content:

The European Randomized Study of Screening for Prostate Cancer (ERSPC), which included 186,160 men, suggests that PSA screening can lower prostate cancer mortality rates. John Schieszer has the details in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters